News Focus
News Focus
Replies to #90032 on Biotech Values
icon url

DewDiligence

02/02/10 1:02 PM

#90033 RE: dewophile #90032

Agree on all counts—a very long half-life is not a desirable attribute for an HCV drug that's presumably vying for inclusion in a combination pill.